
Male, Lung Neoplasms, Esophageal Neoplasms, Rectal Neoplasms, Prostatic Neoplasms, Uterine Cervical Neoplasms, Breast Neoplasms, Radiotherapy Dosage, Combined Modality Therapy, Otorhinolaryngologic Neoplasms, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Humans, Female
Male, Lung Neoplasms, Esophageal Neoplasms, Rectal Neoplasms, Prostatic Neoplasms, Uterine Cervical Neoplasms, Breast Neoplasms, Radiotherapy Dosage, Combined Modality Therapy, Otorhinolaryngologic Neoplasms, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Humans, Female
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
